Contrast Agents Regain ‘Drug’ Status, But Ophthalmic Products Still Subject To Genus Decision

Legislative rider effectively reverses Genus court ruling, and now US FDA must treat contrast agents, radioactive drugs and OTC monograph drugs as drugs. However, the agency will have to assess case-by-case whether certain ophthalmic products meet the definition of ‘drug’ or ‘device.’